Chemical industry – Page 19
-
BusinessVaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
BusinessIndustry expects problems ahead after initial relief over Brexit deal
Uncertainty still looms over regulation and logistics
-
WebinarGood practices in data analytics
Join us to learn how the University of Limerick develops skills and knowledge of data analytics via their Pharmaceutical Manufacturing Technology Centre (PMTC)
-
BusinessChaos on Capitol Hill prompts changes in pharma and biotech
Dow won’t donate to lawmakers who refused to certify presidential votes, others like 3M, Amgen, BIO and PhRMA pause political giving to reassess
-
OpinionClimate action plans will point to methane metrics in 2021
It’s good to see policymakers and companies making methane emissions data a priority
-
OpinionSylvia Stoesser – the first female chemist at Dow
Rebecca Trager explores the story of a pioneering industrial researcher, named on 29 patents, but whose research career ended with motherhood
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
BusinessCybercriminals target Covid-19 vaccines
Officials in the UK and US warn of threat from cyber-attacks that steal data related to Covid-19 vaccines and aim to disrupt the supply chain
-
BusinessAstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
BusinessPfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
BusinessFatal explosion at US chemical plant
Blast at Optima facility killed one and injured three others
-
BusinessOxford Biotrans makes its grapefruit compound out of oranges
Using their patented enzymes, Oxford Biotrans’ mission is to create new routes to useful chemicals – starting with their natural-grade food and fragrance products
-
OpinionStirring in my sleep
Cut off from the lab after 40 years, Derek Lowe returns to the bench in his dreams
-
ArticleImmunity trend puts vitamin fortification centre stage
Manufacturers look to meet consumer demand for immune-strengthening products in the wake of Covid-19
-
Business4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
-
BusinessUK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
BusinessBrexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
-
BusinessOxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease